Product Images Tamsulosin Hydrochloride
View Photos of Packaging, Labels & Appearance
- Label Image - lbl713350398
- Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1
- Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2
- Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3
- Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4
- Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5
- Chemical Structure - tamsulosin str
Product Label Images
The following 7 images provide visual information about the product associated with Tamsulosin Hydrochloride NDC 71335-0398 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl713350398
This is a description for a medication called Tamsulosin HCI that comes in a package prepared by Bryant Ranch Prepach Burbank in California. The medication is in the form of an olive green and orange opaque capsule labeled as "0.4mg Capsule." The capsule packaging advises to keep all drugs out of reach of children and store at room temperature between 20-25°C (68-77°F). The medication is a generic equivalent of Flomax 0.4mg Capsule and has an NDC number of 7133503981. The expiration date is listed as MM/YY but is not provided in the text.*
Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1
The text is a figure description and does not provide enough information to generate a useful description.*
Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2
Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3
The text provides a graph (Figure 2B) indicating the mean change in the total AUA symptom score (0 to 35) for three treatments: O-0.08mg, LNt 0.4mg, and a placebo. The x-axis represents the duration of treatment (weeks), and the y-axis represents the mean change in total AUA symptom score. The graph shows the mean changes for different time points (0, 1, 2, 5, 9, 13, and LOCF). There is no non-English text.*
Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4
Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5
This text describes a figure labeled as "Figure 3B" which shows the mean increase in peak urine flow rate (measured in mL/Sec) for study 2. The x-axis of the figure represents the duration of treatment in weeks, while the y-axis represents the peak urine flow rate. The figure includes a line graph with a colored line indicating treatment and a grayscale line indicating no treatment. The figure also includes a legend indicating which line corresponds to which treatment.*
Chemical Structure - tamsulosin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
